ABSTRACT 1 PRDM9 has been identified as a meiosis-specific protein that plays a key role in determining the location of 2 meiotic recombination hotspots. Although it is well-established that PRDM9 is a trans-acting factor directing the 3 double strand break machinery necessary for recombination to its DNA binding site, the details of PRDM9 4 binding and complex formation are not well known. It has been suggested in several instances that PRDM9 acts 5 as a multimer in vivo; however, there is little understanding about the protein stoichiometry or the components 6 inducing PRDM9 multimerization. In this work, we used in vitro binding studies and mass spectrometry to 7 characterize the size of the PRDM9 multimer within the active DNA-protein complex of two different murine 8 PRDM9 alleles, PRDM9
INTRODUCTION 19
In most mammals, including humans and mice, the meiosis-specific protein PR-domain containing 20 protein 9 (PRDM9) was identified to play a key role in regulating and determining the location of recombination 21 hotspots [1] [2] [3] [4] [5] and are functionally important in the interaction with components of the DSB machinery, located on the 31 chromatin axis 19, 20 . In addition, H3K4me3 is associated with an open chromatin structure at DSB targets 32 hypothesized to be important for proper DNA pairing between homologues and recognition, which would be 33 otherwise hidden within nucleosomes 21 . Finally, the N-terminal KRAB domain (together possibly with the 34 SSXRD domain) binds to other protein complexes, like EWSR1, CDYL, EHMT2 20 and CXXC1 19, 20 , involved in 35 tethering the target DNA in the loop with the axis where proteins of the DSB machinery are located 22 . Note that 36 PRDM9 interacts with CXXC1, but it is not an essential link for meiotic recombination progression in mice 23 . All 37 four domains of PRDM9 play an important role in the placement of DSBs at hotspot targets recognized by the 38 ZnF-array. Over evolutionary time, species have either lost the complete full length Prdm9 gene, are missing one 39 of the four domains, or have non-functional changes. In those species lacking a functional PRDM9, DSBs occur 40 at PRDM9-independent sites such as transcription start sites (TSS) or CpG islands, as observed in birds and dogs 41 [24] [25] [26] [27] [28] . 42
PRDM9 has been shown to be highly polymorphic between and within species. Most mammals, like 43 humans [3] [4] [5] 29 , chimps [30] [31] [32] , mice 1, 4, 10, 33 , equids 34 and cattle 35 by the other allele, as it was shown in both humans for the C vs. A allele 5 and mice for the 9R vs. 13R allele 2 or 49 the B6 vs. CAST allele 33, 36 . 50
Prdm9 has been identified also as a speciation gene playing an essential role in hybrid sterility 37 . 51
Interestingly, only certain combinations of heterozygous Prdm9 alleles are incompatible in a specific genetic 52 background 38, 39 . The process is not yet fully understood, but it has been observed that the heterozygous Prdm9 53 alleles preferentially activate target sequences at the non-self homolog, which is influenced by sequence erosion at 54 recombination hotspots. This leads to an asymmetric binding of PRDM9, and thus also an asymmetric distribution 55 sequence to one of the chromosomes pairs restoring the symmetric hotspot distribution 42 . It was also 64 demonstrated that removing or overexpressing a certain PRDM9 allele, and therefore increasing the PRDM9 65 dosage, could rescue fertility in sterile hybrid crosses 39 . This suggests that a certain number of active hotspot sites 66 are required for successful meiotic progression, which among others is controlled by the dosage of PRDM9. 67
Recently, it has been observed that PRDM9 can form functional multimeric complexes 14, 36 . How this 68 multimerization affects the activity of PRDM9 is not known, but it could play a role in the preferential hotspot 69 usage by the dominant PRDM9 allele in heterozygous individuals, where the binding is driven by the stronger 70 allele 36 . Multimerization could also play a role in hybrid sterility, in which otherwise active alleles are 71 sequestered in a heteromer resulting in a more symmetric distribution of DSBs and synapsis (reviewed in 21 ). 72
To date observations of PRDM9 multimerization are based on cell systems over-expressing two different 73 alleles of PRDM9 with distinct tags 14, 36 . However, it is not known how many PRDM9 units form the multimer, 74 which is key information to understand how PRDM9 interacts at a molecular level and also influences PRDM9 75 dosage, especially in the context of PRDM9 heterozygosity. In addition, it is still unknown whether different ZnF 76 arrays within a multimeric complex interact also with multiple DNA targets. By addressing these aspects, we will 77 gain important insights in the nature of the ZnF-DNA interaction and DNA targeting. 78
In this work, we performed an in vitro analysis of the DNA-PRDM9 complex using electrophoretic 79 mobility shift assays (EMSA) to infer the stoichiometry of the active complex. We show that the molecular 80 weight (MW) of a complex can be inferred from its electrophoretic migration distance under non-denaturing 81 conditions. In combination with mass spectrometry, we estimated that PRDM9 forms a trimer when actively 82 bound to DNA. This trimer was observed for two different PRDM9 alleles, PRDM9
Cst and PRDM9
Dom2
. 83
Moreover, the trimer formation is mediated within the variable ZnF array and at least 5 out of 11 ZnFs are 84 sufficient to form a stable DNA-binding trimer. Finally, our data suggest a model in which only one of the ZnF 85 array is involved in DNA binding; whereas, the other two ZnFs likely are involved in protein-protein interactions. 86 sites (tandem-Hlx1) derived from the Hlx1 hotspot known to specifically bind the PRDM9 Cst ZnF array (ZnF
Cst

) of 96
Mus musculus castaneus origin 9, 12 . If different units (single PRDM9 proteins) within the PRDM9 multimer 97 interact simultaneously with the two DNA binding sites of the tandem-Hlx1, then there is no change in the overall 98 MW of the complex and migration distance. In contrast, if two independent complexes form with the tandem-99 Hlx1, then this higher MW complex has a slower migration. 100
For the design of the single and tandem-Hlx1, we considered previous experiments showing that ZnF Cst 101 bound specifically 34 nucleotides, yet unspecific flanking DNA improved the binding 12 . Thus, the DNA sequence 102 contained either one or two adjacent 34bp specific target sites plus 20-23bp flanking regions (single-Hlx1 or 103 tandem-Hlx1 with 75bp or 114bp, respectively), as shown in Figure S1 . We observed that the single-Hlx1 DNA formed a complex (shifted band) at very low protein concentrations. 107
The intensity of the shift increased with protein concentration saturating the free DNA and forming a complex 108 ( Figure 1A ), as observed before 12 . For the tandem-Hlx1, two different states of the complex were detected with 109 increasing protein concentrations: a lower-shift and a super-shift. The lower-shift was observed at low PRDM9 110 concentrations, and as PRDM9 concentrations were increased, a second super-shift became visible ( Figure 1B) . A 111 super-shift is observed regularly in EMSA when a second protein (e.g. antibody against the protein) is incubated 112 with the complex, resulting in a large change of the overall MW slowing the migration of the complex to a super-113 shift 43 . In our case, the super-shift can be explained by the binding of an additional PRDM9 to the second 114 available Hlx1 site with increasing protein concentrations. Since the binding sites are on one DNA strand, the two 115 complexes stay linked forming a super-shift. The dynamics are as follows: the lower-shift increases at low 116 PRDM9 concentrations until half of the sites are filled ( Figure 1B and 1D) . With further increase in protein, the 117 second Hlx1 target site gets bound, with the effect that the intensity of the lower-shift diminishes and is replaced 118 by an increasing super-shift. The overall free DNA decays at the same rate for both the single and tandem-Hlx1 119 ( Figure 1A-1D ). These results demonstrate that the multiple ZnF arrays within a multimer do not interact 120 simultaneously with several DNA binding sites. Instead, the second free site on the tandem-Hlx1 is bound by the 121 ZnF array of an independent PRDM9 multimer. An alternative explanation is that PRDM9 is a monomer, and thus 122 only one ZnF array interacts with the DNA; however, this is not the case as we show in the next sections. 123
A quantitative analysis ( Figure 1E and 1F) shows that the intensity of the sum of the shifts (lower + super-124 shift) is correlated directly with the affinity of the ZnF. We estimated that the tandem-Hlx1 DNA has a similar 125 affinity to the ZnF as the single-Hlx1 (KD= 35nM and 48nM, respectively), also corroborating that the tandem6 adjacent PRDM9 specific sequences. Note that these KD values are slightly higher than obtained with the same 129 approach in a previous work (24.5nM ± 2.6) 12 ). A possible reason for this deviation in the KD could be the much 130 shorter incubation times used here (60 minutes vs. 90 hours) with an effect in the equilibrium states and ultimately 131 the KD when loading the EMSA. 132
133
The molecular weight of the PRDM9-DNA complex can be determined by native gel electrophoresis 134 Native gel electrophoresis can be used to infer the molecular weight (MW) of negatively charged, linear 135 chains such as DNA or SDS-denatured proteins, for which the MW is inversely proportional to the logarithm of 136 the migration distance in a gel [44] [45] [46] . The migration of these linear, negatively charged chains is independent of the 137 total charge and conformation of the molecule and follows the 'reptation principle'. This model proposes that the 138 negative charge on one end of the molecule is sufficient to drive the rest of the molecule that migrates snakelike 139 through the pores of the gel, oriented by the negative charge on one end and pulling the rest of the molecule 140 through the same path [45] [46] [47] [48] [49] (for more details see Supplementary_Notes). 141
We developed two different strategies, assay I and assay II, to infer the molecular weight of the DNA-142 PRDM9 complex in a polyacrylamide gel under non-denaturing conditions. As before, we used EMSA for 143 visualizing the mobility of the complex and further estimate the protein stoichiometry by comparison to a 144 standard series. In both assays, the migration of the complex was driven by the reptation of the long linear DNA 145 overhangs flanking the complex. 146
In the more conservative assay I, our standards were PRDM9 ZnF complexes (ZnF + DNA) with a constant 147 conformation-charge, but different molecular weights given by the length of the flanking DNA. Previous methods 148 used a similar strategy of constant charge and conformation to derive a function of relative migration distance vs. 149 molecular weight in a Ferguson plot 44, 50, 51 . For this purpose, we used in assay I the tandem-Hlx1 known to form 150 one or two linked complexes, as described in the previous section. Specifically, we designed DNA fragments of 151 different lengths with one binding site (single-Hlx1) or two consecutive (tandem-Hlx1) binding sites, all with 152 increasing non-specific flanking sites ( Figure 2A and Figure S1 ) resulting in a lower-shift (red rectangles) for the 153 single-Hlx1 or lower-and super-shift (purple rectangles in Figure 2B ) bands for the tandem-Hlx1 sequences. The 154 lower-shifts (one complex) were used as standards to infer the MW of the second complex in the super-shifts 155 ( Figure 2B and Figure S2 ). The standard curve with nine measurements resulted in a very high correlation of a 156 linear regression function plotted in a log-scale ( Figure 2C ). The MW of the protein constructs was then estimated 157 from the derived regression function as the average of four independent measurements (super-shift) within one
In the simplified assay II, the MW of the different protein constructs was inferred by comparing the 160 migration of the complex directly to free DNA standards ( Figure 2D -E). In order to further validate this strategy, 161
we assessed PRDM9 constructs with different charges and conformations by adding different tags and PRDM9 162 domains, originating from the PRDM9 Cst and PRDM9 Dom2 variants ( Figure 3A) . By comparing the migration of 163 the shifted bands (lower-shifts, red rectangles) relative to the migration of a DNA ladder (free DNA of different 164 sizes), we estimated the MW of the PRDM9 complex and derived the protein units within each construct ( Figure  165 3B, Figure S3 and Table S1 ). 166
We compared the two developed assays by testing four ZnF Cst constructs with both methods and did not 167 observe differences in the estimated protein stoichiometry (Table 1 and Table S1 ). This indicates that the 168 migration of the complex in the native gel is driven invariably by the reptation of the long flanking DNA chain, 169 independent of protein charge or conformation. 170
171
PRDM9 interacts with the DNA as a trimer 172
In order to assess the protein stoichiometry of the PRDM9 multimer and the PRDM9 domain mediating this 173 multimerization, we designed eleven different protein constructs missing selected domains of the PRDM9 Cst and 174
PRDM9
Dom2 variants ( Figure 3A ). In addition, constructs carried different tags like eYFP (enhanced yellow 175 fluorescent protein), MBP (maltose binding protein), or Halo (His6-HaloTag) and were produced by distinct 176 expression systems, like cell-free in vitro expression (IVE) or bacterial expression and protein lysate protocols 177 (Table S1 and Supplementary_Methods). The majority of the bacterially expressed constructs were used as crude 178 lysates without further purification obtained from the whole-cell fraction (WC) with cell debris or from the 179 soluble fraction (SN) excluding cell debris. Only the lysate preparation for the construct containing the Halo tag 180 was semi-pure and included a purification step based on ion exchange chromatography by using SP Sepharose 181 (for details see Supplementary_Methods). 182
We assessed that the full-length PRDM9 interacts with DNA as a trimer ( Figure 3B and Table S1 ). In fact, all 183 of our tested constructs, including the ZnF domain of two different murine alleles, PRDM9
Cst and PRDM9 We analysed the data from assay I and assay II independently with an ANOVA test and observed some 194 differences between the PRDM9 constructs (detailed analysis can be found in Materials and Methods and 195 Supplementary_Statistical_Analysis). Since, these differences can neither be explained by construct size, 196 additional tags, expression system nor theoretical isoelectric point ( Figure 3 and Table S1 ), we suggest that this is 197 due to experimental variations. (either the long or the short DNA), and we expect two shifts in addition to the two free DNA sequences (Model 211 1). Alternatively in model 2, the trimer binds two or more DNA sequences, and we expect five bands: three shifts 212 and two free DNA sequences shown in Figure 4A . Our results clearly show the formation of a DNA-protein 213 complex with either the short or the long DNA, but not both, demonstrating that only one of the three ZnF arrays 214 in the multimer actively binds to the DNA ( Figure 4B ). The remaining two ZnF arrays could be involved in 215 protein-protein interactions stabilizing the multimer. 216
The mass spectrometric data of the Halo-ZnF Cst 1-11 showed that there were no additional bacterial peptides 224 in the complex based on searches of the NCBI or SwissProt databases. Next, the measured monoisotopic m/z 225 value of the peptide mass fingerprint spectra was compared to the theoretical m/z values of Halo-ZnF Cst 1-11 226 using ProteinProspector (University of California, www.proteinprospector.ucsf.edu). The 34 expected peptide 227 ions from the expressed protein were detected in the peptide mass fingerprint spectrum (Table S2) Table S2 and  240   Table S3 ?. 241 242 DISCUSSION 243
PRDM9 binds DNA as a trimer 244
In this work, we developed an approach to infer the MW of the PRDM9-DNA complex from native gel 245 electrophoresis using an in vitro binding assay (EMSA) with two independent strategies (assay I and assay II; 246
Figure 2), which differed in the type of regression standards (lower-shift vs. free DNA, respectively) and inferred 247 measurements (super-shift vs. lower-shift, respectively). Here we report that the multimer is formed by three 248 PRDM9 units when actively bound to a specific DNA target sequence. It is possible that the ZnF array also forms 249 larger or smaller complexes, but our gel images indicate that the majority of the active PRDM9 that specifically 250 binds to DNA is formed by a trimer. This is congruent with previous studies also reporting that PRDM9 forms 251 functional multimeric complexes of at least two or more units 14, 36 . Moreover, our data demonstrate that 252 multimerization is independent of the tested PRDM9 allele (PRDM9 Cst and PRDM9
Dom2
). Neither functional tags 253 like eYFP, MBP and Halo, nor expression systems (bacterial or in vitro expression) or protein purity did influence 254 the binding or protein stoichiometry in all eleven tested protein constructs, confirming that our approach is very 255 robust. By fingerprinting the PRDM9-DNA complex with mass spectrometry, we confirmed that the complex is 256 solely formed by PRDM9 and DNA in vitro. 257
258
PRDM9 multimerization is mediated within the ZnF domain 259
We removed the KRAB, SSXXD, PR/SET domain, the single ZnF0, and even shortened stepwise the 260 PRDM9 ZnF array to the smallest construct with only five out of 11 ZnFs. In none of these constructs we 261 observed a change in stoichiometry. Thus, we conclude that the PRDM9 multimerization is mediated within the 262 variable DNA-binding ZnF domain. This is also congruent with a recent study using co-IP experiments of 263 different co-expressed PRDM9 constructs reporting that PRDM9-PRDM9 interactions occur within the ZnF 264 In previous studies using yeast two-hybrid systems, co-transfection of isoforms and gel shift assays, 288 complexes formed by maC2H2 (like Ikaros or Roaz) were interpreted as 'higher order structures' or dimers, but 289 no exact stoichiometry was established 62, 63 . These ZnF proteins preferentially formed multimers in order to bind 290 specific target DNA sequences with a higher binding affinity and efficiency (reviewed in 52 ). Multimerization is 291 usually mediated via ZnFs not participating in DNA recognition using two different modes: hydrophobic 292 interactions through the ZnF surface 64 , as it was shown for proteins like GL1 65 and SW15 66 , or ZnF-ZnF 293 interaction mediated by the same amino acids conferring the DNA sequence specificity 67, 68 . Among others, this 294 was shown for Ikaros, a hematopoietic cell-specific protein playing a major role in regulating lymphocyte 295 development (reviewed in 69 ). Ikaros consists of four adjacent ZnFs close to the N-terminus and are involved in 296 sequence-specific DNA binding 70 ; whereas, the two C-terminal ZnFs are highly selective for dimerization 67 . 297
In contrast, our truncation product ZnF2-6 of PRDM9
Cst showed that five ZnFs are sufficient to form a 298 multimer. It is very likely that all these ZnFs are in direct contact with DNA, since at least five ZnFs are required 299 for a stable and sequence-specific DNA binding, as was shown in several instances 12, 14 . Thus, in case of PRDM9 300 it seems more likely that a hydrophobic interaction of the ZnF surface confers the protein-protein interaction; 301 however, we cannot exclude the possibility that in a longer PRDM9 ZnF array, a more specific ZnF-ZnF 302 interaction might take place. 303
304
Multimerization of PRDM9 is not exclusive of heteromers 305
ZnF proteins can form both homo-and heterodimers; however, they prefer interacting with the same protein 306 rather than forming heteromeric complexes (reviewed in 52, 67 . So far, the question whether PRDM9 can form 307 homo-and heteromeric complex has not been fully addressed. Baker and colleagues first discovered PRDM9 to 308 multimerize and demonstrated that it can form active homo-and heteromeric complexes. This was shown in cells 309 co-transfected with two identical PRDM9 allele constructs (PRDM9 C ) harbouring different tags (FLAG and V5) 310 or with two different alleles, PRDM9
A and PRDM9 C . Immunoprecipitation experiments using anti-FLAG 311 followed by Western blot with anit-V5 showed that V5-PRDM9 C was only detected when co-expressed with 312
FLAG-PRDM9
A or FLAG-PRDM9 C . This was confirmed by Chromatin-Immunoprecipitation (ChIP) measuring 313 the presence of PRDM9
A at C-defined hotspots when expressed simultaneously with PRDM9 C . Moreover, when 314 co-expressed with a catalytically-dead PRDM9 C mutant, PRDM9 A could replace the catalytic activity and 315 trimethylated H3K4 at C-defined hotspots 36 . 316 Similar experiments expressing both human PRDM9 B and chimp PRDM9 suggested a higher preference of 317 homo-than heteromeric complex formation. This was shown by competitive co-IP experiments where three 318 constructs were co-transfected to cells harbouring different tags like chimp-V5, chimp-HA and human-HA. In this 319 case chimp-HA was detected more efficiently than human-HA after IP pulldown for chimp-V5 and vice versa 14 . 320
Similarly, no evidence for heteromer formation was observed in vivo by the trans-complement methyltransferase 321 activity in mice heterozygous for PRDM9 Dom2 and PRDM9 Cst-YF (PRDM9 Cst variant with a methyltransferase 322 knockout mutation) 71 . The question is whether potential formation of a heteromer also depends on ZnF 323 divergence, since those amino acids defining the variability do not only recognize specific DNA but also possibly 324 mediate ZnF-ZnF interactions 67, 68 . 325
326
The PRDM9 trimer binds only one DNA target 327
Since we showed that multimer formation is coordinated within the DNA-binding ZnF domain, we proposed 328 different models of how many DNA molecules can be bound by the polymeric complex. Our data showed that the 329 tandem-Hlx1 with two binding sites forms two independent complexes and that the PRDM9 trimer binds only to 330 one DNA molecule in an equimolar mixture of long and short DNA sequences. This strongly suggests that the 331 multimer only binds one DNA target molecule at a time, even though three ZnF domains would be available. It is 332 possible that the two other ZnF domains are important in mediating stable ZnF-ZnF interaction, explaining why 333
ZnF proteins are often found in multimers. However, we cannot exclude that the other domains of PRDM9 (e.g. 
What is the biological effect of PRDM9 multimerization 340
Given that the trimeric PRDM9 complex recognizes only one target molecule at a time, the effective dosage 341 of PRDM9 may be affected especially in heterozygous individuals. It has been shown in several instances that 342 PRDM9 dosage plays a crucial role in fertility with both homo-and hemizygous Prdm9 null mice showing 343 complete or partial sterility due to a drastically reduced number of active hotspots 7, 41 . 344
One explanation for Prdm9 allele incompatibility in heterozygous individuals is the combination of both 345 native and virgin PRDM9 target sequences of two evolutionary distant alleles within a certain genetic 346 background, whereas mainly the virgin sequences are activated, resulting in hotspot asymmetry 33, 40 . Hotspot 347 (a)symmetry may also be affected by the dominance of certain Prdm9 alleles over others. As an example, it has 348 been shown in humans and mice heterozygous for Prdm9, that hotspots specific for one allele have been enriched, 349
suggesting that this allele is dominant, like PRDM9 C is dominant over PRDM9 A and PRDM9 Cst over PRDM9 . This may also depend on the binding affinity of PRDM9 for its target, which probably differs between 351 variants 15 and therefore affects PRDM9 dominance. In case of PRDM9 multimerization within a heterozygous 352 context, different variants are physically coupled in a 2:1 ratio. This could affect the dosage of PRDM9, since oneallele is over-the other is underrepresented, as well as, the distribution of (a)symmetric hotspots if one allele is 354 dominant and binds better to its target. In this case, the weaker allele is outnumbered and probably even masked 355 within the multimeric complex with its activity strongly suppressed within the multimer, leading to a more 356 symmetric distribution of hotspots and thus higher fertility. 12 . Therefore, the inserts were prepared via specific PCR amplification and cloned into the desired vector using 379 restriction enzyme-based cloning. The different constructs were designed to involve different tags like His-tag, 380 maltose binding protein (MBP) or enhanced yellow fluorescent protein (eYFP) as well as different parts of the 381
Prdm9
Cst or Prdm9 Dom2 coding region. One PRDM9 Cst construct included a His6-HaloTag (Halo), which was 382 kindly provided by the Petkov Lab (Center for Genome Dynamics, the Jackson Laboratory, Bar Harbor, ME 383 the domains of PRDM9 or repeats of the ZnF array were removed. In total, we tested eleven different protein 418 constructs (for details see Supplementary_Methods): eYFP-PRDM9 Dom2 . This large range of different sized protein constructs varied in conformation and charge; yet, rendered 421 similar relative mobilities in EMSA confirming that in our set-up the migration of the complexes was mainly 422 dependent of its molecular weight. 423
Assay I. For multimer assay I we used the advantage of the tandem-Hlx1 molecules resulting in super-shift 424 bands representing a second PRDM9 complex bound. Each experiment was used to analyse only one type of 425 PRDM9 construct. The protein was bound to six single-Hlx1 (75bp, 740bp, 856bp, 1053bp, 1147bp, 1460bp) and 426 four tandem-Hlx1 (114bp, 232bp, 352bp, 468bp) , or three single-Hlx1 (75bp, 543bp, 740bp) and two tandem-427 Hlx1 (114bp, 232bp; for very small protein constructs, see Figure S2B Assay II. In order to evaluate the multimer assay II experiments, one EMSA was used to investigate eight 442 different types of PRDM9 constructs which was replicated for four times. All protein constructs were bound to a 443 DNA fragment of 75bp (for PRDM9
Cst constructs the Hlx1 hotspot was used; for PRDM9 Dom2 construct the Pbx1 444 hotspot was used). Unspecific reference DNA fragments of 2585bp (usDNA1) and 75bp (usDNA2) were included 445 in each lane. The calculation of the PRDM9 stoichiometry was performed the same way as for assay I. However, 446 a ladder of unbound DNA (75bp, 114bp, 273bp, 543bp, 740bp) were used as standards instead of the lower-shift. 447
The stoichiometry was derived from the migration distance of the lower-shift band.
Statistical analysis 451
We tested for significant differences of calculated protein stoichiometry between different PRDM9 constructs 452
for assay I and II separately using an ANOVA taking normality and homoscedasticity into account. A detailed 453 description of the statistical analysis can be found in Supplementary_Statistical_Analysis. Table S4 ) in a 30µl reaction by incubating for 5 minutes at 466 95°C and cooling down for one hour. The hybridized DNA sample was supplemented with 1x NEB buffer 2.1 467 (NEB), 1mM dNTPs (Biozym) and 6.75 units T4 DNA polymerase (NEB) in a 56µl reaction and incubated for 1 468 hour at 12°C to start DNA extension. To remove remaining single-stranded DNA fragments, the sample was 469 digested with Exonuclease I (NEB) as described in Supplementary_Methods. In order to purify the DNA, the 470 sample was mixed with 2µl Co-Precipitant Pink (VWR) and 0,5 volumes of 5M NH4OAc. Furthermore, two 471 volumes of pure ethanol were added and mixed by inverting. For total DNA precipitation, the sample was 472 incubated at -20°C for 30 minutes followed by centrifugation at maximum speed for 30min at 4°C. The 473 supernatant was discarded and the pellet washed with 1ml 80% ethanol. After a final centrifugation step of 5min 474 at full speed and 4°C, the supernatant was carefully discarded and the pellet was dried at room temperature. The 475 DNA sample was dissolved in 20µl nuclease-free water (Sigma-Aldrich). 476 477 Prepare binding reaction. In order to prepare the PRDM9-DNA binding complex, 7µl of semi-pure Halo-478
ZnF
Cst 1-11 were mixed with 2µM Hlx1-75bp DNA in a 20µl binding reaction supplemented by 1x binding buffer 479 (10mM Tris, 50mM KCl, 0.05% NP-40, 50µM ZnCl2) and incubated for 60min at room temperature. The reaction 480 was prepared twice. 481
Gel electrophoresis. 20µL sample solution was supplemented by 1x DNA loading dye (Thermo Scientific) 483 and applied onto the gel. Electrophoresis was performed on 5% mini-PROTEAN TBE (Biorad), 10 wells 30µL 484 gels using 1xTBE (89mM Tris, 89mM boric acid, 3mM EDTA) as running buffer. Constant voltage was set to 485 100V (50mA/gel), after 40 min the separation was stopped. 486
After gel electrophoresis coomassie staining with CBB R250 was performed. The gel was fixed (45% EtOH, 487 5% acetic acid in water) for 45min and subsequently stained (0,1% CBB R250 in 45% EtOH, 5% acetic acid in 488 water) for one hour. Destaining was performed using two solutions: destain solution I (40% EtOH, 7% acetic acid 489 in water) for 30min, followed by destain solution II (5% EtOH, 7% acetic acid in water) overnight for clearing the 490 background to obtain distinct protein bands. 491
492
In-gel tryptic digestion. The protein gel band was excised and cut into small cubes. To remove contaminants 493 and CBB R250 stain various washing steps each lasting 15-min were applied: once with water, two times with 494 ACN/water (1:1), once with 100% ACN and once with ACN/50mM NH4HCO3 pH8.5 (1:1, v/v). Gel pieces were 495 dried in a vacuum centrifuge. Subsequently disulfide bridges were reduced with 100mM DTT (15.4 mg/mL in 496 50mM NH4HCO3 pH 8.5) for 45min at 56°C and alkylated with 55mM iodoacetamide (10.2 mg/mL in 50mM 497 NH4HCO3 pH 8.5) for 30min at room temperature in the dark. Another washing step with ACN/50mM NH4HCO3 498 pH 8.5 (1:1) was performed. Gel pieces were dried in the vacuum centrifuge. Subsequently the gel pieces were 499 incubated with 15µL digestion solution (12.5ng/µL Trypsin in 50mM NH4HCO3) for 15min and then coated with 500 25µL 50mM NH4HCO3 pH 8.5. The protein was digested at 37°C overnight. 501
Peptide extraction from the gel pieces was performed by using ACN/50mM NH4HCO3 pH 8.5 (1:1), 502 ACN/0.1% TFA (1:1) and 100% ACN each step lasting 15min. Extracts were pooled and lyophilised in a vacuum 503 centrifuge. 504 505 MALDI sample preparation. First, the stainless steel MALDI target was prepared by application of 1µL 506 CHCA matrix solution (6mg/mL in acetone). After evaporation of acetone at room temperature a thin 507 homogenous layer of matrix crystals was obtained. 508
Peptides were dissolved in 0.1% TFA and desalted using C18 ZipTips. The tips were activated with 509 ACN/0.1% TFA (1:1) and equilibrated with 0.1% TFA. After binding of the peptides, salts and detergents were 510 removed by washing the tips five times with 0.1% TFA. Elution was performed using 1.5µL ACN/0.1% TFA 511 (6:4) which were directly applied onto the prepared CHCA layer on the MALDI target. The sample spot was dried 512 at room temperature and subsequently transferred into the AXIMA Performance instrument. 513 an AXIMA Performance instrument (Shimadzu; Kyoto, Japan). The AXIMA Performance is equipped with a 517 nitrogen laser (λ=337nm) and it was operated in positive ion, reflectron mode using pulsed extraction. Peptide 518 mass fingerprint (PMF) mass spectra were acquired by averaging 500 and MS/MS spectra by averaging up to 519 2500 unselected and consecutive laser shots. No smoothing algorithm was applied prior to data analysis. 520
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ZnF
Cst 1-11, which was incubated with a 75bp DNA fragment from the Hlx1 hotspot for 60min and cut out from a 765 native 5% acrylamide gel after coomassie staining. After treatment with trypsin digestion, DTT reduction and 766 carbamethylation using iodacetamide, the complex was analysed using a MALDI-TOF Axima Performance 767 instrument (Shimadzu). The spectrum shows the peptide mass fingerprint of the PRDM9-DNA complex with all 768 prominent peaks matching the peptides of our protein. 769
